07:00 , Mar 18, 2013 |  BC Week In Review  |  Company News

AsymmetRx Medical Inc., Biocare, Roche diagnostic news

Biocare and AsymmetRx settled a 2007 patent infringement suit alleging Biocare infringed AsymmetRx's patents covering tumor protein p63 ( TP63 ; p63). As part of the settlement, Biocare received worldwide rights from Roche's Ventana Medical...
08:00 , Dec 5, 2011 |  BC Week In Review  |  Company News

Basilea infectious, dermatology news

In October, HBM asked for the meeting and proposed four nominees "to support the evaluation and implementation of strategic decisions and to unlock Basilea's untapped potential." HBM subsequently lowered the number of its nominees to...
01:45 , Nov 30, 2011 |  BC Extra  |  Company News

Basilea bolsters board

Shareholders of Basilea Pharmaceutica AG (SIX:BSLN) elected three additional directors to the biotech's five-member board Tuesday at a meeting requested by shareholder HBM BioVentures. The new members are: Thomas Rinderknecht, chairman of cardiovascular company Canyon...
07:00 , Apr 4, 2011 |  BC Week In Review  |  Company News

Biocare, Eisai deal

Eisai's Morphotek Inc. subsidiary partnered with Biocare to develop and commercialize an immunohistochemical diagnostic kit to detect human folate receptor 1 ( FOLR1 ; FR-alpha ). Morphotek's mAb against the folate receptor will be used...
08:00 , Mar 8, 2010 |  BC Week In Review  |  Company News

Pathway Genomics, Rochem A.G. deal

Pathway Genomics and Instituto de Referencia Andino (IRA), a division of Rochem A.G.'s Rochem Biocare Group, will identify genetic markers linked to common health conditions in Latin and Hispanic populations. The markers will be used...
07:00 , Jul 20, 2009 |  BC Week In Review  |  Company News

Ceragenix, Nobel Biocare Holding AG deal

Nobel Biocare received an exclusive option to license rights to Ceragenix's Cerashield antimicrobial technology for certain oral and cranial maxillofacial applications. Nobel Biocare, which develops and markets dental implants, will have up to 11 months...
08:00 , Feb 20, 2006 |  BC Week In Review  |  Company News

Biocare, Epitomics deal

The companies partnered to develop reagents and kits for immunohistochemistry-based diagnostics. Epitomics will supply Biocare with rabbit monoclonal antibodies, and Biocare will be responsible for developing the kits. Biocare Medical LLC , Concord, Calif.  ...
07:00 , Oct 10, 2005 |  BC Week In Review  |  Company News

Reliant sales and marketing update

Reliant launched in the U.S. Omacor omega-3-acid ethyl esters as an adjunct to diet to reduce triglycerides in adults with very high triglyceride levels. Reliant received exclusive marketing and distribution rights to Omacor from Pronova...
08:00 , Dec 6, 2004 |  BC Week In Review  |  Company News

Pronova Biocare AS, Reliant sales and marketing update

Reliant obtained exclusive marketing and distribution rights to Pronova's Omacor omega-3 acid ethyl esters in the U.S. Last month, FDA approved Omacor as an adjunct to diet to reduce triglycerides in adults with very high...
07:00 , May 13, 2002 |  BC Week In Review  |  Company News

Quidel management update

Quidel Corp. (QDEL), San Diego, Calif.   Business: Diagnostics/Imaging   Hired: Don Kennard as VP of regulatory, clinical and quality systems, formerly VP of R&D, regulatory affairs and quality assurance at Nobel Biocare Inc.  ...